Concepedia

Yvonne C. Lo

YC

Statistics

Publications

8

Citations

352

H-Index

8

Active since

2001

Affiliations

Bristol-Myers Squibb (United States)(Current)

Wilmington University

Experimental Station

Yvonne C. Lo is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacology, and ligand binding.

Publications per year

2001–2010

8

Publications

8

Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-α

Percy H. Carter, Peggy Scherle, Jodi A. Muckelbauer et al. · Proceedings of the National Academy of Sciences · 2001 · 140 citations · Full text

, , +16

Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-Dependent tumor necrosis factor-α antagonists

Matthew E. Voss, Percy H. Carter, Andrew J. Tebben et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 70 citations · Full text

, , +7

Discovery of Disubstituted Cyclohexanes as a New Class of CC Chemokine Receptor 2 Antagonists

Robert J. Cherney, Ruowei Mo, Dayton T. Meyer et al. · Journal of Medicinal Chemistry · 2008 · 44 citations · Full text

, , +17

Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists

Robert J. Cherney, David J. Nelson, Yvonne C. Lo et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 24 citations · Full text

, , +14

γ-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists

Robert J. Cherney, Ruowei Mo, Dayton T. Meyer et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 23 citations · Full text

, , +14

1–5 of 8